Literature DB >> 23669412

Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease.

Anne E Holland1, Catherine J Hill, Ian Glaspole, Nicole Goh, Leona Dowman, Christine F McDonald.   

Abstract

BACKGROUND: Reduced chronotropic response to maximal exercise has been associated with poor survival in people without respiratory disease. The contribution of chronotropic response to exercise limitation and survival in interstitial lung disease (ILD) is not well defined. This study investigated the relationships between chronotropic response during 6-min walk test, exercise capacity and survival in ILD.
METHODS: Eligible participants had ILD, were ambulant and free of heart failure and beta blocker therapy. Chronotropic response during the 6-min walk test was defined as peak heart rate (HR) minus resting HR. Survival was recorded at four years.
RESULTS: Sixty-two participants (40 idiopathic pulmonary fibrosis) were included, with mean (SD) TLCO 50(18)% predicted and 6-min walk distance (6MWD) 377 (127) metres. A smaller chronotropic response was associated with reduced 6MWD (r = 0.65, p < 0.001). Independent predictors of 6MWD were chronotropic response, peak oxygen uptake on cardiopulmonary exercise test; right ventricular systolic pressure on echocardiogram; and age. This model explained 83% of the variance in 6MWD, with 24% of the variance attributable to chronotropic response. A chronotropic response during 6-min walk test of less than 20 beats per minute was an independent predictor of death at four years (odds ratio 10.71, 95% confidence interval 2.67-42.94) in a model that also included oxygen desaturation and forced vital capacity.
CONCLUSIONS: Impaired chronotropic response to 6-min walk test is associated with reduced 6MWD and reduced survival in ILD, independent of physical fitness and pulmonary hypertension. Investigation of the mechanisms underlying attenuated HR response to exercise in ILD is warranted.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23669412     DOI: 10.1016/j.rmed.2013.04.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

1.  Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.

Authors:  Benjamin Strauss; Yassine Sassi; Carlos Bueno-Beti; Zeki Ilkan; Nour Raad; Marine Cacheux; Malik Bisserier; Irene C Turnbull; Erik Kohlbrenner; Roger J Hajjar; Lahouaria Hadri; Fadi G Akar
Journal:  J Mol Cell Cardiol       Date:  2018-11-28       Impact factor: 5.000

2.  Frailty and maximal exercise capacity in adult lung transplant candidates.

Authors:  Aimee M Layton; Hilary F Armstrong; Matthew R Baldwin; Anna J Podolanczuk; Nicole M Pieszchata; Jonathan P Singer; Selim M Arcasoy; Kimberly S Meza; Frank D'Ovidio; David J Lederer
Journal:  Respir Med       Date:  2017-08-10       Impact factor: 3.415

Review 3.  The key questions in rehabilitation in thoracic surgery.

Authors:  Kajan Mahendran; Babu Naidu
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.

Authors:  David M Macdonald; Elise F Palzer; Asghar Abbasi; Arianne K Baldomero; Surya P Bhatt; Richard Casaburi; John E Connett; Mark T Dransfield; Nathaniel T Gaeckle; Takudzwa Mkorombindo; Harry B Rossiter; William W Stringer; Nicholas B Tiller; Chris H Wendt; Dongxing Zhao; Ken M Kunisaki
Journal:  Respir Med       Date:  2022-02-18       Impact factor: 3.415

5.  Functional clinical impairments and frailty in interstitial lung disease patients.

Authors:  Pierre-François Tremblay Labrecque; Geneviève Dion; Didier Saey
Journal:  ERJ Open Res       Date:  2022-10-17

6.  Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study.

Authors:  Kiyoshi Migita; Toru Arai; Yuka Jiuchi; Yasumori Izumi; Nozomi Iwanaga; Chieko Kawahara; Eiichi Suematsu; Tomoya Miyamura; Hiroshi Tsutani; Yojiro Kawabe; Ryutaro Matsumura; Shunsuke Mori; Shiro Ohshima; Shigeru Yoshizawa; Yasuo Suenaga; Fumitaka Ogushi; Masaharu Kawabata; Hiroshi Furukawa; Toshihiro Matsui; Seiji Bito; Shigeto Tohma
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

7.  Impairments that influence physical function among survivors of childhood cancer.

Authors:  Carmen L Wilson; Prasad L Gawade; Kirsten K Ness
Journal:  Children (Basel)       Date:  2015

8.  Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline.

Authors:  Alexandra Nagy; Tamas Nagy; Abigel Margit Kolonics-Farkas; Noemi Eszes; Krisztina Vincze; Eniko Barczi; Adam Domonkos Tarnoki; David Laszlo Tarnoki; György Nagy; Emese Kiss; Pal Maurovich-Horvat; Aniko Bohacs; Veronika Müller
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

9.  Factors associated with the 6-minute walk distance in patients with systemic sclerosis.

Authors:  Sébastien Sanges; Jonathan Giovannelli; Vincent Sobanski; Sandrine Morell-Dubois; Hélène Maillard; Marc Lambert; Céline Podevin; Nicolas Lamblin; Pascal De Groote; Jean-François Bervar; Thierry Perez; Régis Matran; Martine Rémy-Jardin; Pierre-Yves Hatron; Éric Hachulla; David Launay
Journal:  Arthritis Res Ther       Date:  2017-12-15       Impact factor: 5.156

10.  Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Toshiaki Matsuda; Hiroyuki Taniguchi; Masahiko Ando; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Koichi Nishimura; Osamu Nishiyama; Koji Sakamoto; Yoshinori Hasegawa
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.